공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 일렉트로포레이션 기기 시장(2021-2028년)

Global Electroporation Instruments Market - 2021-2028

리서치사 DataM Intelligence
발행일 2021년 10월 상품 코드 1022288
페이지 정보 영문 200 Pages
가격
US $ 4,350 ₩ 5,149,000 PDF & Excel (Single User License)
US $ 4,850 ₩ 5,741,000 PDF & Excel (Multiple User License)
US $ 7,850 ₩ 9,292,000 PDF & Excel (Enterprise License)


세계의 일렉트로포레이션 기기 시장(2021-2028년) Global Electroporation Instruments Market - 2021-2028
발행일 : 2021년 10월 페이지 정보 : 영문 200 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 일렉트로포레이션 기기 시장 규모는 향후 확대될 것으로 예측됩니다.

일렉트로포레이션 기기는 전기 전도도에 근거한 분자생물학적 기술을 이용하여, 세포막에 투과성을 발생시키고, 목적 분자를 수동적으로 통과시킵니다. 일렉트로포레이션 기기는 박테리아나 포유류 세포 등 다양한 종류의 세포에 외래 단백질을 도입하는 데에 효과적입니다.

세계의 일렉트로포레이션 기기(Electroporation Instruments) 시장에 대해 조사했으며, 시장 개요, 제품별/용도별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 세계의 일렉트로포레이션 기기 시장 조사 방법과 범위

  • 조사 방법
  • 조사 목적과 조사 범위

제2장 세계의 일렉트로포레이션 기기 시장 : 시장의 정의와 개요

제3장 세계의 일렉트로포레이션 기기 시장 : 개요

  • 제품별 시장 개요
  • 용도별 시장 개요
  • 지역별 시장 개요

제4장 세계의 일렉트로포레이션 기기 시장 : 시장 역학

  • 시장에 영향을 미치는 요인
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 영향 분석

제5장 세계의 일렉트로포레이션 기기 시장 : 업계 분석

  • Porter의 산업 분석
  • PEST 분석
  • 공급망 분석
  • 가격 분석
  • 규제 분석
  • 상환 분석
  • 충족되지 않은 욕구

제6장 세계의 일렉트로포레이션 기기 시장 : COVID-19 분석

  • 시장에서의 COVID-19 분석
    • COVID-19 이전 시장 시나리오
    • COVID-19 현재 시장 시나리오
    • COVID-19 이후 또는 향후 시나리오
  • COVID-19 가격 역학
  • 수급 스펙트럼
  • 팬데믹 기간의 시장에 관련된 정부 이니셔티브
  • 제조업체의 전략적 이니셔티브
  • 결론

제7장 세계의 일렉트로포레이션 기기 시장 : 제품별

  • 서론
    • 시장 규모 분석 및 전년대비 성장 분석(%), 제품별
    • 시장 매력도 지수
  • 토탈 일렉트로포레이션 시스템
    • 서론
    • 시장 규모 분석, 백만 달러, 2018-2028년 및 전년대비 성장 분석(%), 2020-2028년
  • 진핵생물 일렉트로포레이션 시스템
  • 미생물 일렉트로포레이션 시스템

제8장 세계의 일렉트로포레이션 기기 시장 : 용도별

  • 서론
    • 시장 규모 분석 및 전년대비 성장 분석(%), 용도별
    • 시장 매력도 지수
  • 단백질 생산
    • 서론
    • 시장 규모 분석, 백만 달러, 2018-2028년 및 전년대비 성장 분석(%), 2020-2028년
  • 생물의학 연구
    • 형질전환 모델
    • 암 연구
    • 유전자 및 단백질 발현 연구
    • Drug Discovery and Development를 위한 세포 기반 마이크로어레이
  • 치료 딜리버리
    • 바이오치료제(Biotherapeutics)
    • 전기화학요법/전기면역요법

제9장 세계의 일렉트로포레이션 기기 시장 : 지역별

  • 서론
    • 시장 규모 분석, 백만 달러, 2018-2028년 및 전년대비 성장 분석(%), 2020-2028년, 지역별
    • 지역별 시장 매력도 지수
  • 북미
    • 서론
    • 주요 지역 고유의 역학
    • 시장 규모 분석 및 전년대비 성장 분석(%), 제품별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 용도별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 국가별
  • 유럽
    • 서론
    • 주요 지역 고유의 역학
    • 시장 규모 분석 및 전년대비 성장 분석(%), 제품별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 용도별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 국가별
  • 남미
    • 서론
    • 주요 지역 고유의 역학
    • 시장 규모 분석 및 전년대비 성장 분석(%), 제품별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 용도별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 국가별
  • 아시아태평양
    • 서론
    • 주요 지역 고유의 역학
    • 시장 규모 분석 및 전년대비 성장 분석(%), 제품별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 용도별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 국가별
  • 중동 및 아프리카
    • 서론
    • 주요 지역 고유의 역학
    • 시장 규모 분석 및 전년대비 성장 분석(%), 제품별
    • 시장 규모 분석 및 전년대비 성장 분석(%), 용도별

제10장 세계의 일렉트로포레이션 기기 시장 : 경쟁 구도

  • 주요 발전과 전략
  • 기업 점유율 분석
  • 제품 벤치마킹
  • 주목해야 할 주요 기업
  • 파괴적 기술을 보유한 기업
  • 스타트업 기업

제11장 세계의 일렉트로포레이션 기기 시장 : 기업 개요 개요

  • Bio-Rad Laboratories
    • 기업 개요
    • 타입 포트폴리오와 설명
    • 주요 하이라이트
    • 재무 개요
  • BEX Co. Ltd
  • Celetrix LLC
  • Merck KGaA
  • Eppendorf AG
  • Harvard Bioscience Inc.(BTX)
  • Thermo Fisher Scientific, Inc
  • MaxCyte Inc
  • Lonza Group
  • Mirus Bio LLC
  • Guangzhou Tingmay Beauty Equipment Co., Ltd
  • ALLFOND INDUSTRIAL LIMITED
  • Shanghai Apolo Medical Technology Co., Ltd

제12장 세계의 일렉트로포레이션 기기 시장 : DataM

  • 부록
  • 당사 및 서비스에 대해
  • 문의
LSH 21.09.02

Market Overview

The global electroporation instruments market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Electroporation instruments use a molecular biology technology based on electrical conductivity to generate permeability in the cell membrane through which molecule of interest can pass through it passively. Electroporation instruments are beneficial in introducing foreign proteins to different cell types, such as bacterial or mammalian cells.

Market Dynamics

The electroporation instruments market growth is driven by the Increasing research and development funding by public and private bodies. In addition, with the increase in the technological advancement in the field of nanotechnology, biotechnology, and pharmacology, increases its penetration rates, a collaboration between major market players and academic institutions, funding for research in electrophoresis technique, increasing focus on next-generation sequencing techniques, are some of the factors driving the growth of electroporation instrument market.

Development of vaccine delivery system using electroporation technology, is expected to drive the growth in the forecast period

The electroporation technique is widely preferred to enhance nucleic acid uptake with the DNA to generate an immune response against an antigen when the vaccine is delivered through the skin. The rise in the prevalence of infectious diseases and other skin disorders is likely to drive the demand for electroporation instruments. The potential of the electrophoresis method in locating the local antigen expression in the epidermis offers a significant advantage to patients. Electroporation technique creates an inflammatory environment, and hence, its association with DNA vaccination would result in strong expression of vaccine antigen, thus driving the global electroporation instruments market.

Progress in gene editing techniques, is expected to drive the growth in the forecast period

The advancements in gene-editing technologies, including regularly- interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins or transcription activator-like effector nucleases (TALENs), have enabled the researchers to curate targeted sequence-specific changes across the DNA- a factor that is expected to rise the adoption of electroporation instruments. As the advancements in gene-editing techniques occur at a steady pace, the prospects of this market continue to look at a bright future. Moreover, as applications of gene editing techniques continue to increase research and development, the adoption of electroporation instruments is likely to witness considerable growth. In addition, significant advancements in the electroporation instruments and electrodes coupled with the increasing compatibility with cutting-edge gene-editing technology are likely to play a key role in the overall development of the global electroporation instruments market.

Non-specific transport and other complications is likely to hamper the market growth

The electroporation methods have some disadvantages compared to other delivery systems. In some cases, non-specific transport of the material can result in an ion imbalance, leading to improper cell function and death. Irreversible electroporation could lead to cell homeostasis loss, widely considered an unconventional mode for cell death. The electroporation method causes complications and skin edema, as compared to other physical methods.

COVID-19 Impact Analysis

The COVID-19 impact on the global electroporation instruments market is expected to remain moderate in 2020, as the research and development activities are likely to remain unaffected. Moreover, the increasing adoption of gene-editing technology across the healthcare sector globally is likely to continue in 2020, due to which the electroporation instruments market is projected to witness the steady growth. As the precision medicines are playing an imperative role in assisting researchers and scientists to evaluate the new coronavirus, the demand for electroporation instruments is likely to grow. In addition, CRISPR-based diagnostics are increasingly being used to accurately diagnose a range of medical diseases, including the new COVID-19 infection- another factor that is expected to propel the market growth for electroporation instruments COVID-19 era.

Segment Analysis

The total electroporation system segment is expected to hold largest share in this market segment

An increase in the burden of diseases across the globe has prompted various healthcare organizations to focus on drug discovery and drug development. These studies require experimental drugs on human and other eukaryotic cells to study their mechanism of action and their safety profile. The rise in demand for multifaceted devices that can be used for all types of cell studies leading to overall cost-effectiveness, is anticipated to drive the total electroporation system during the forecast period.

The protein production segment is expected to hold largest share in this market segment

Protein production through the expression of mammalian cells is a major aspect of the biotechnology industry. Proteins such as erythropoietin and human growth hormones are efficiently utilized to treat cancers, infectious diseases, and autoimmune diseases. Moreover, most autoimmune diseases and cancer are treated by biotherapeutics, where protein is the primary ingredient for the production of biotherapeutics. To achieve this, electroporation is considered the highly preferred process in the delivery of protein to study the expression and development of treatment in the genomic engineering process.

Geographical Analysis

North America region holds the largest market share of global electroporation instruments market

The North American region dominated the global electroporation instruments market, followed by Europe. The rise in prevalence of cancer and autoimmune diseases in North America fueled the transfection technology market. Moreover, biotherapeutic drugs are highly preferred for the treatment of cancer and autoimmune diseases, and an increase in usage of these drugs is estimated to fuel the demand for transfection, as transfection is extensively employed to produce biotherapeutic drugs.

Competitive Landscape

The global electroporation instruments market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include BEX Co. Ltd., Celetrix LLC, Merck KGaA, Eppendorf AG, Harvard Bioscience Inc. (BTX), Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, MaxCyte Inc., Lonza Group, and Mirus Bio LLC, Guangzhou Tingmay Beauty Equipment Co., Ltd, ALLFOND INDUSTRIAL LIMITED, Shanghai Apolo Medical Technology Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, In January 2018, Harvard Biosciences Inc. acquired Data Sciences International, Inc. worth US$ 71.1 Mn, which is a leading global player offering preclinical products, solutions, systems, and services to pharmaceutical, biotechnology, CROs, research laboratories, and government research institutes.

Electroporation Instruments Market Key Companies to Watch

Bio-Rad Laboratories

  • Overview: Bio-Rad, founded in 1952, is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With employees, more than 7,800, headquarters Hercules, California, USA. Bio-Rad is among the top five life science companies globally, providing instruments, software, consumables, reagents, and content for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. It is the world leader in clinical quality control products, services, and information systems, ensuring the accuracy and validity of clinical test results.
  • Product Portfolio: The Company's portfolio comprised of include life science research and clinical diagnostics.

Product - The Gene Pulser Xcell System is a flexible, modular electroporation system for transfecting every cell type from primary, suspension, and difficult-to-transfect cells, including T cells, to bacteria and fungi.

Why Purchase the Report?

  • Visualize the composition of the electroporation instruments market segmentation by product, application and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in electroporation instruments market by analysing trends and co-development deals.
  • Excel data sheet with thousands of data points of electroporation instruments market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global electroporation instruments market report would provide an access to an approx. 53 market data table, 42 figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Electroporation Instruments Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Electroporation Instruments Market - Market Definition and Overview

3. Global Electroporation Instruments Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Global Electroporation Instruments Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Development of vaccine delivery system using electroporation technology
      • 4.1.1.2. Progress in gene editing techniques
    • 4.1.2. Restraints:
      • 4.1.2.1. Non-specific transport and other complications
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Electroporation Instruments Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Electroporation Instruments Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Electroporation Instruments Market - By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Total Electroporation System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Eukaryotic Electroporation System
  • 7.4. Microbial Electroporation System

8. Global Electroporation Instruments Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Protein Production*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Bio-Medical Research
    • 8.3.1. Transgenic models
    • 8.3.2. Cancer Research
    • 8.3.3. Gene and Protein Expression Studies
    • 8.3.4. Cell-based Microarrays for Drug Discovery and Development
  • 8.4. Therapeutic Delivery
    • 8.4.1. Biotherapeutics
    • 8.4.2. Electro-chemotherapy and Electro-immunotherapy

9. Global Electroporation Instruments Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Global Electroporation Instruments Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Global Electroporation Instruments Market- Company Profiles

  • 11.1. Bio-Rad Laboratories*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. BEX Co. Ltd
  • 11.3. Celetrix LLC
  • 11.4. Merck KGaA
  • 11.5. Eppendorf AG
  • 11.6. Harvard Bioscience Inc. (BTX)
  • 11.7. Thermo Fisher Scientific, Inc
  • 11.8. MaxCyte Inc
  • 11.9. Lonza Group
  • 11.10. Mirus Bio LLC
  • 11.11. Guangzhou Tingmay Beauty Equipment Co., Ltd
  • 11.12. ALLFOND INDUSTRIAL LIMITED
  • 11.13. Shanghai Apolo Medical Technology Co., Ltd LIST NOT EXHAUSTIVE

12. Global Electroporation Instruments Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us
Back to Top
전화 문의
F A Q